Vol. 3 No. 6-S4 (2009): CUAJ December Suppl 4

View Vol. 3 No. 6-S4 (2009): CUAJ December Suppl 4

Published: 2013-05-01

Supplement-Introduction

Key issues in bladder cancer management

Wassim Kassouf

S179
- PDF

Review

Screening for bladder cancer: the best opportunity to reduce mortality

Yves Fradet

S180-S183
- PDF
Chemoprevention in bladder cancer: What’s new?

Jean-Baptiste Lattouf

S184-S187
- PDF
The optimal management of T1 high-grade bladder cancer

Kenneth G. Nepple, Michael A. O’Donnell

S188-S192
- PDF
Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer

Venu Chalasani, Joseph L. Chin, Jonathan I. Izawa

S193-S198
- PDF
The management of BCG failure in non-muscle-invasive bladder cancer: an update

Alexandre R. Zlotta, Neil E. Fleshner, Michael A. Jewett

S199-S205
- PDF
Role of lymphadenectomy for invasive bladder cancer

Faysal A. Yafi, Wassim Kassouf

S206-S210
- PDF
Management of the urethra in urothelial bladder cancer

Androniki Kanaroglou, Bobby Shayegan

S211-S214
- PDF
Perioperative chemotherapy for muscle-invasive bladder cancer

Peter Black, Alan So

S223-S227
- PDF
Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapy

Robert S. Svatek, Arlene Siefker-Radtke, Colin P. Dinney

S228-S231
- PDF
Personalized medicine in advanced urothelial cancer: when to treat, how to treat and who to treat

Behfar Ehdaie, Steven C. Smith, Dan Theodorescu

S232-S236
- PDF
Surveillance strategies after definitive therapy of invasive bladder cancer

Ilias Cagiannos, Christopher Morash

S237-S232
- PDF

Point-Counterpoint

The case for prostate capsule-sparing radical cystectomy in selected patients

Laurence Klotz, Jehonathan Pinthus

S215-S219
- PDF
Is sparing the prostate still considered radical cystectomy? The case against prostate-sparing cystectomy for bladder cancer

Ahmed Kotb, Armen G. Aprikian

S220-S222
- PDF